Somatus is a leading provider of value-based kidney care for health plans, health system, and provider groups.
Somatus' mission is to be the world’s best provider of integrated kidney care for those with or at-risk of kidney disease.
Somatus was founded in 2016 by Ikenna Okezie and Anthony Welters. The company is headquartered in McLean, Virginia.
Somatus' vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation.
The Somatus model uses actionable intelligence from its propriety RenalIQ® technology platform to power field-based care team efforts and connect major kidney care stakeholders.
Somatus partners with health systems, nephrology and primary care groups and health plans to offer value-based care for patients at different stages of kidney disease. The company serves more than 150,000 patients across the U.S.
Somatus is backed by Wellington Management, Longitude Capital, Optum Ventures, Deerfield Management Company, RA Capital Management, GIC, Fidelity Management & Research Company, Blue Venture Fund, Town Hall Ventures, Flare Capital, and others. The company raised $325M in Series E round on Feb 23, 2022. This brings Somatus' total funding to $465.1M to date. The latest round valued the company at over $2.5B post-money.